SOS Limited (SOS) Announces Exercise of Warrants for Approximately $96.7 Million in Gross Proceeds
- S&P 500, Dow climb for third day and close at records
- Tesla (TSLA) China Numbers 'Robust' - Wedbush
- Apple (AAPL) Shares Seen as 'Attractive' as Recent Checks Show Continuously Strong Demand - Citi
- Amazon.com warehouse workers vote to reject forming union in Alabama
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
SOS Limited (NYSE: SOS) (the "Company" or "SOS") today announced the agreement by several accredited investors to exercise certain warrants to purchase up to an aggregate of 23,880,000 of its American Depositary Shares ("ADSs") issued by the company on February 10, 2021, at an exercise price of $4.05.
The ADSs issuable upon exercise of the warrants are registered pursuant to a registration statement on Form F-3ASR (File No. 333-253402) which became effective by the Securities and Exchange Commission (SEC) on February 23, 2021. The gross proceeds to the company from the exercise of the warrants are expected to be approximately $96.7 million, prior to deducting fees and estimated offering expenses.
Maxim Group LLC is acting as the exclusive financial advisor for the offering.
In consideration for the immediate exercise of the warrants for cash, the exercising holders will receive new unregistered warrants to purchase ADSs in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "1933 Act"). The warrants will be exercisable into an aggregate of up to 23,880,000 ADSs, at an exercise price of $7.00 per ADS, which have a term of exercise approximately equal to five years.
SOS intends to use the proceeds from the offering to develop its recently launched cloud cryptocurrency mining and cryptocurrency security and insurance business as well as for working capital and general corporate use.
The new warrants described above were offered pursuant to an applicable exemption from the registration requirements of the 1933 Act and, along with the ADSs issuable upon their exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. The company has agreed to file a prospectus supplement with the SEC covering the resale of the ADSs issuable upon exercise of the new warrants.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Spruce Point Short Porch Group (PRCH), Sees 50-70% Downside
- Novo Integrated Sciences (NVOS) Prices $8.0 Million Registered Direct Offering
- Outset Medical Inc. (OM) Prices Primary and Upsized Secondary Public Offering at $53.50/sh